These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30003804)

  • 1. Trends in the "Off-Label" Use of GnRH Agonists Among Pediatric Patients in the United States.
    Lopez CM; Solomon D; Boulware SD; Christison-Lagay E
    Clin Pediatr (Phila); 2018 Oct; 57(12):1432-1435. PubMed ID: 30003804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment patterns with histrelin acetate subcutaneous implants vs. leuprolide injections in children with precocious puberty: a real-world study using a US claims database.
    Silverman LA; Han X; Huang H; Near AM; Hu Y
    J Pediatr Endocrinol Metab; 2021 Aug; 34(8):961-969. PubMed ID: 34147047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations.
    Klein KO; Soliman AM; Bonafede M; Nelson JK; Grubb E
    J Med Econ; 2020 Apr; 23(4):407-414. PubMed ID: 31766907
    [No Abstract]   [Full Text] [Related]  

  • 4. Health Care Utilization and Economic Burden in Patients with Central Precocious Puberty: An Assessment of the Commercially Insured and Medicaid Populations.
    Klein K; Soliman AM; Bonafede M; Nelson JK; Grubb E
    J Manag Care Spec Pharm; 2019 Jul; 25(7):836-846. PubMed ID: 31232203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the use of puberty blockers among transgender children in the United States.
    Lopez CM; Solomon D; Boulware SD; Christison-Lagay ER
    J Pediatr Endocrinol Metab; 2018 Jun; 31(6):665-670. PubMed ID: 29715194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists.
    Miller BS; Shukla AR
    Clin Ther; 2010 Sep; 32(10):1749-51. PubMed ID: 21194598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.
    Kappy M; Stuart T; Perelman A; Clemons R
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1087-9. PubMed ID: 2507570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histrelin Hydrogel Implant--Valera: Histrelin implant, LHRH-Hydrogel implant, RL 0903, SPD 424.
    Drugs R D; 2005; 6(1):53-5. PubMed ID: 15801868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.
    Eugster EA; Clarke W; Kletter GB; Lee PA; Neely EK; Reiter EO; Saenger P; Shulman D; Silverman L; Flood L; Gray W; Tierney D
    J Clin Endocrinol Metab; 2007 May; 92(5):1697-704. PubMed ID: 17327379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcomes of precocious puberty: an update.
    Fuqua JS
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2198-207. PubMed ID: 23515450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty.
    Wu MH; Lin SJ; Wu LH; Cheng YC; Chou YY; Pan HA
    Reprod Biomed Online; 2005 Jul; 11(1):18-21. PubMed ID: 16102281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty.
    Albano MC; Latronico AC; Arnhold IJ; Domenice S; Bloise W; Mendonca BB
    J Pediatr Endocrinol Metab; 1997; 10(5):499-503. PubMed ID: 9401906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial.
    Silverman LA; Neely EK; Kletter GB; Lewis K; Chitra S; Terleckyj O; Eugster EA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2354-63. PubMed ID: 25803268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty.
    Mul D; de Muinck Keizer-Schrama SM; Oostdijk W; Drop SL
    Horm Res; 1999 Dec; 51(6):270-6. PubMed ID: 10640887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.
    Lee PA; Klein K; Mauras N; Lev-Vaisler T; Bacher P
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3153-9. PubMed ID: 24926950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.